Basic info
Industry
biotechnology research
Sectors
Biotechnology
Neurodegeneration
Field stimulation and voltage control assays
Drug Discovery research services
CNS disease research services
Customized assay development
High-capacity in vitro assays
Target-based screeening
Chronic pain research services
Neuropsychiatry
High-throughput transfection
Medical
Phenotypic screening
Preclinical compound validation
Date founded
2001
Funding rounds raised
Total raised
$7M
from 2 investors over 2 rounds
C
Cellectricon AB raised $7M on May 26, 2004
Investors: Capital Growth Investments Inc and Karolinska Development